The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Knudson, R. J., Lebowitz, M. D., Holberg, C. J., & Burrows, B. A. (1983) · PubMed · doi:10.1164/arrd.1983.127.6.725 · Cited by 1,907
MIYAMOTO, S., NAGAYA, N., SATOH, T., KYOTANI, S., SAKAMAKI, F., FUJITA, M., NAKANISHI, N., & MIYATAKE, K. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9906015 · Cited by 1,154
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 906
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Idiopathic Interstitial Pneumonia: What Is the Effect of a Multidisciplinary Approach to Diagnosis?
Flaherty, K. R., King, T. E., Raghu, G., Lynch, J. P., Colby, T. V., Travis, W. D., Gross, B. H., Kazerooni, E. A., Toews, G. B., Long, Q., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-147oc · Cited by 673
Idiopathic Pulmonary Fibrosis: Relationship between Histopathologic Features and Mortality
KING, T. E., SCHWARZ, M. I., BROWN, K., TOOZE, J. A., COLBY, T. V., WALDRON, J. A., FLINT, A., THURLBECK, W., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2001056 · Cited by 628
Cited by
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
A global view of pulmonary hypertension
Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., Jing, Z.-C., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,039
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Pulmonary hypertension in chronic lung disease and hypoxia
Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01914-2018 · Cited by 757
Self-citationPulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Nalysnyk, L., Cid-Ruzafa, J., Rotella, P., & Esser, D. (2012) · European Respiratory Review · doi:10.1183/09059180.00002512 · Cited by 552
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Le Pavec, J., Prévot, G., Mal, H., Humbert, M., Simonneau, G., Cordier, J.-F., & GERM“O”P (2010) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 478
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Raghu, G., Amatto, V. C., Behr, J., & Stowasser, S. (2015) · European Respiratory Journal · doi:10.1183/13993003.02316-2014 · Cited by 463
The six‐minute walk test: a useful metric for the cardiopulmonary patient
Rasekaba, T., Lee, A. L., Naughton, M. T., Williams, T. J., & Holland, A. E. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01880.x · Cited by 417
Meltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
Hoeper, M. M., Barberà, J. A., Channick, R. N., Hassoun, P. M., Lang, I. M., Manes, A., Martinez, F. J., Naeije, R., Olschewski, H., Pepke-Zaba, J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.008 · Cited by 399
Holland, A. E., Hill, C. J., Conron, M., Munro, P., & McDonald, C. F. (2008) · Thorax · doi:10.1136/thx.2007.088070 · Cited by 391
Hamada, K., Nagai, S., Tanaka, S., Handa, T., Shigematsu, M., Nagao, T., Mishima, M., Kitaichi, M., & Izumi, T. (2007) · Chest · doi:10.1378/chest.06-1466 · Cited by 390
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Shorr, A. F., Wainright, J. L., Cors, C. S., Lettieri, C. J., & Nathan, S. D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00107206 · Cited by 377
Self-citation2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Noordegraaf, A. V., Beghetti, M., et al. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.01.002 · Cited by 357
Idiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
Kreuter, M., Ehlers-Tenenbaum, S., Palmowski, K., Bruhwyler, J., Oltmanns, U., Muley, T., Heussel, C. P., Warth, A., Kolb, M., & Herth, F. J. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151425 · Cited by 351
Lung transplantation for idiopathic pulmonary fibrosis
George, P. M., Patterson, C. M., Reed, A. K., & Thillai, M. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30502-2 · Cited by 297
DePianto, D. J., Chandriani, S., Abbas, A. R., Jia, G., N'Diaye, E. N., Caplazi, P., Kauder, S. E., Biswas, S., Karnik, S. K., Ha, C., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2013-204596 · Cited by 287
Lefèvre, G., Dauchet, L., Hachulla, E., Montani, D., Sobanski, V., Lambert, M., Hatron, P., Humbert, M., & Launay, D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38029 · Cited by 274
Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis
Nathan, S. D., Shlobin, O. A., Ahmad, S., Urbanek, S., & Barnett, S. D. (2007) · Chest · doi:10.1378/chest.06-2485 · Cited by 270
Self-citationThe therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi, V., Chaudhuri, N., Torrisi, S. E., Kahn, N., Müller, V., & Kreuter, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0021-2019 · Cited by 265
Pulmonary hypertension in interstitial lung disease: Fig. 1—
Behr, J., & Ryu, J. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00171307 · Cited by 263
Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis
Collard, H. R., Anstrom, K. J., Schwarz, M. I., & Zisman, D. A. (2007) · Chest · doi:10.1378/chest.06-2101 · Cited by 254
Nathan, S. D., Behr, J., Collard, H. R., Cottin, V., Hoeper, M. M., Martinez, F. J., Corte, T. J., Keogh, A. M., Leuchte, H., Mogulkoc, N., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30250-4 · Cited by 253
Self-citationLaunay, D., Humbert, M., Berezne, A., Cottin, V., Allanore, Y., Couderc, L.-J., Bletry, O., Yaici, A., Hatron, P.-Y., Mouthon, L., et al. (2011) · Chest · doi:10.1378/chest.10-2473 · Cited by 99
Sildenafil Therapy and Exercise Tolerance in Idiopathic Pulmonary Fibrosis
Jackson, R. M., Glassberg, M. K., Ramos, C. F., Bejarano, P. A., Butrous, G., & Gómez-Marín, O. (2010) · Lung · doi:10.1007/s00408-009-9209-8 · Cited by 92
“The echocardiographic pressure estimates (Table 4) and NT-pro BNP data cited earlier demonstrate that this cohort was at risk for pulmonary hypertension, consistent with the literature [1, 12, 13].”
ResultDoubková, M., Švancara, J., Svoboda, M., Šterclová, M., Bartoš, V., Plačková, M., Lacina, L., Žurková, M., Binková, I., Bittenglová, R., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12700 · Cited by 87
Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M., Vittinghoff, E., Collard, H. R., & Vancheri, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.01587-2018 · Cited by 79
Hayes, D., Black, S. M., Tobias, J. D., Kirkby, S., Mansour, H. M., & Whitson, B. A. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.06.024 · Cited by 66
Myeloid-derived suppressor cells are necessary for development of pulmonary hypertension
Bryant, A. J., Shenoy, V., Fu, C., Marek, G., Lorentsen, K. J., Herzog, E. L., Brantly, M. L., Avram, D., & Scott, E. W. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0214oc · Cited by 47
Hayes, D., Higgins, R. S., Black, S. M., Wehr, A. M., Lehman, A. M., Kirkby, S., & Whitson, B. A. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.004 · Cited by 41
Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease
Wells, A., Devaraj, A., Renzoni, E. A., & Denton, C. P. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1684020 · Cited by 36
Candidate Selection, Timing of Listing, and Choice of Procedure for Lung Transplantation
Kreider, M., Hadjiliadis, D., & Kotloff, R. M. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.02.001 · Cited by 24
De Oliveira, N. C., Osaki, S., Maloney, J., Cornwell, R. D., & Meyer, K. C. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezr079 · Cited by 15
“Another potential complication, secondary pulmonary hypertension, frequently occurs as the disease progresses and lung function worsens, and patients with significant pulmonary hypertension have poorer survival than IPF patients without this complication [21].”
Influence of pulmonary hypertension on survival in advanced lung disease
Hayes, D., Black, S. M., Tobias, J. D., Mansour, H. M., & Whitson, B. A. (2015) · Lung · doi:10.1007/s00408-015-9696-8 · Cited by 14
Lee, J., & Song, J.-U. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e48 · Cited by 10
Metadata
- Authors
- Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 129
- Issue
- 3
- Pages
- 746-752
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2123137799
- Cited by
- 879
- References
- 35
- FWCI
- 30.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.